ingap peptide
Peptideexperimental
Clinical trial activity
5 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
5
Phase 3
0
Phase 4
0
Earliest trial started Dec 1, 2001 (NCT00034255)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- ingap peptide
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02204397 | Phase 2 | Nov 1, 2015 | McGill University |
| NCT00995540 | Phase 2 | Nov 1, 2009 | Exsulin Corporation, Mayo Clinic, McGill University |
| NCT00071409 | Phase 2 | Oct 1, 2003 | Exsulin Corporation |
| NCT00071422 | Phase 2 | Oct 1, 2003 | Exsulin Corporation |
| NCT00034255 | Phase 1/Phase 2 (Phase 2) | Dec 1, 2001 | GMP Companies |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Exsulin Corporation | For profit | 3 | 3 | 1 | 2003 |
| McGill University | Academic/Hospital | 2 | 1 | 1 | 2009 |
| GMP Companies | For profit | 1 | 1 | 1 | 2001 |
| Mayo Clinic | Academic/Hospital | 1 | 0 | 1 | 2009 |
4 organizations
Page 1 / 1